MEG biomarker of Alzheimer's disease: Absence of a prefrontal generator during auditory sensory gating

Magnetoencephalography (MEG), a direct measure of neuronal activity, is an underexplored tool in the search for biomarkers of Alzheimer's disease (AD). In this study, we used MEG source estimates of auditory gating generators, nonlinear correlations with neuropsychological results, and multivariate analyses to examine the sensitivity and specificity of gating topology modulation to detect AD. Our results demonstrated the use of MEG localization of a medial prefrontal (mPFC) gating generator as a discrete (binary) detector of AD at the individual level and resulted in recategorizing the participant categories in: (1) controls with mPFC generator localized in response to both the standard and deviant tones; (2) a possible preclinical stage of AD participants (a lower functioning group of controls) in which mPFC activation was localized to the deviant tone only; and (3) symptomatic AD in which mPFC activation was not localized to either the deviant or standard tones. This approach showed a large effect size (0.9) and high accuracy, sensitivity, and specificity (100%) in identifying symptomatic AD patients within a limited research sample. The present results demonstrate high potential of mPFC activation as a noninvasive biomarker of AD pathology during putative preclinical and clinical stages. Hum Brain Mapp 38:5180–5194, 2017. © 2017 Wiley Periodicals, Inc.

[1]  Margot J. Taylor,et al.  Magnetoencephalography: From Signals to Dynamic Cortical Networks , 2019, Functional Neuroimaging.

[2]  Sylvain Baillet,et al.  Magnetoencephalography for brain electrophysiology and imaging , 2017, Nature Neuroscience.

[3]  S. A. Hussaini,et al.  Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.

[4]  M. Serrano,et al.  PTEN recruitment controls synaptic and cognitive function in Alzheimer's models , 2016, Nature Neuroscience.

[5]  R. Polikar,et al.  P50: A candidate ERP biomarker of prodromal Alzheimer׳s disease , 2015, Brain Research.

[6]  James T. Becker,et al.  A multicenter study of the early detection of synaptic dysfunction in Mild Cognitive Impairment using Magnetoencephalography-derived functional connectivity , 2015, NeuroImage: Clinical.

[7]  Fernando Maestú,et al.  Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment , 2015, The Journal of Neuroscience.

[8]  Timo Grimmer,et al.  Prefrontal Hypometabolism in Alzheimer Disease Is Related to Longitudinal Amyloid Accumulation in Remote Brain Regions , 2015, The Journal of Nuclear Medicine.

[9]  C. Jack,et al.  Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study , 2014, The Lancet Neurology.

[10]  Julia M. Stephen,et al.  Modulatory role of the prefrontal generator within the auditory M50 network , 2014, NeuroImage.

[11]  J. Haueisen,et al.  Early Attentional Modulation of the Neural Network Evoked with the Auditory Paired-click Paradigm: An MEG Study , 2014 .

[12]  H. Soininen,et al.  Harmonized diagnostic criteria for Alzheimer's disease: recommendations , 2014, Journal of internal medicine.

[13]  Arvind Caprihan,et al.  Characterization of a normal control group: Are they healthy? , 2014, NeuroImage.

[14]  Ralph Huonker,et al.  Magnetic Source Localization of Early Visual Mismatch Response , 2013, Brain Topography.

[15]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[16]  Panteleimon Giannakopoulos,et al.  Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals , 2012, BMC Medicine.

[17]  Anastasia Konsta,et al.  Cingulate Neurobiology and Disease, B.A. Vogt (Ed.). Oxford University Press Inc., New York (2009), ISBN: 978-0-19-856696-0 , 2012 .

[18]  A. Vortmeyer,et al.  Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons , 2012, Nature Neuroscience.

[19]  D. Allison,et al.  Treatment Heterogeneity and Individual Qualitative Interaction , 2012, The American statistician.

[20]  Chia-Hsiung Cheng,et al.  Inadequate inhibition of redundant auditory inputs in Alzheimer's disease: An MEG study , 2012, Biological Psychology.

[21]  Huibert D. Mansvelder,et al.  Layer-Specific Modulation of the Prefrontal Cortex by Nicotinic Acetylcholine Receptors , 2012, Cerebral cortex.

[22]  Clifford R Jack,et al.  Testing the Right Target and Right Drug at the Right Stage , 2011, Science Translational Medicine.

[23]  A. Scott,et al.  MEG-SIM: A Web Portal for Testing MEG Analysis Methods using Realistic Simulated and Empirical Data , 2011, Neuroinformatics.

[24]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[25]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[26]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[27]  James T. Becker,et al.  Magnetoencephalography as a Putative Biomarker for Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[28]  Jens Haueisen,et al.  Size matters: MEG empirical and simulation study on source localization of the earliest visual activity in the occipital cortex , 2011, Medical & Biological Engineering & Computing.

[29]  J. Morris,et al.  Alzheimer’s Disease: The Challenge of the Second Century , 2011, Science Translational Medicine.

[30]  Nash N. Boutros,et al.  Relationships between sensory “gating out” and sensory “gating in” of auditory evoked potentials in schizophrenia: A pilot study , 2010, Schizophrenia Research.

[31]  Ana Susac,et al.  Early cortical responses are sensitive to changes in face stimuli , 2010, Brain Research.

[32]  L. Mucke,et al.  Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.

[33]  Yutaka Takayama.  A delayed recall battery as a sensitive screening for mild cognitive impairment: follow-up study of memory clinic patients after 10 years. , 2010, Journal of medical and dental sciences.

[34]  Harry B. M. Uylings,et al.  Cytoarchitectonic and chemoarchitectonic characterization of the prefrontal cortical areas in the mouse , 2010, Brain Structure and Function.

[35]  Andre Rupp,et al.  P50 gating deficit in Alzheimer dementia correlates to frontal neuropsychological function , 2010, Neurobiology of Aging.

[36]  R Irimajiri,et al.  Cortical event-related potentials in preclinical familial Alzheimer disease , 2009, Neurology.

[37]  H. Uylings,et al.  Prefrontal cortex atrophy predicts dementia over a six-year period , 2009, Neurobiology of Aging.

[38]  M. Farlow,et al.  Treatment of mild cognitive impairment (MCI). , 2009, Current Alzheimer research.

[39]  Ana Susac,et al.  Early dissociation of face and object processing: A magnetoencephalographic study , 2009, Human brain mapping.

[40]  John M. Moran,et al.  Evidence for a frontal cortex role in both auditory and somatosensory habituation: A MEG study , 2008, NeuroImage.

[41]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[42]  Cornelis J. Stam,et al.  Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease , 2006, NeuroImage.

[43]  F. Joseph McClernon,et al.  Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization , 2006, Psychopharmacology.

[44]  Julia M. Stephen,et al.  Aging changes and gender differences in response to median nerve stimulation measured with MEG , 2006, Clinical Neurophysiology.

[45]  M. D'Andrea,et al.  Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. , 2006, Current pharmaceutical design.

[46]  R. Coleman,et al.  Positron emission tomography diagnosis of Alzheimer's disease. , 2005, Neuroimaging clinics of North America.

[47]  A. Starr,et al.  Auditory brain-stem, middle- and long-latency evoked potentials in mild cognitive impairment , 2005, Clinical Neurophysiology.

[48]  J. Morris,et al.  Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.

[49]  D. Poeppel,et al.  Dorsal and ventral streams: a framework for understanding aspects of the functional anatomy of language , 2004, Cognition.

[50]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[51]  Robert Freedman,et al.  The genetics of sensory gating deficits in schizophrenia , 2003, Current psychiatry reports.

[52]  P. Fossier,et al.  Cholinergic modulation of the cortical neuronal network , 2003, Pflügers Archiv.

[53]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[54]  Richard M. Leahy,et al.  Electromagnetic brain mapping , 2001, IEEE Signal Process. Mag..

[55]  D. Small,et al.  Alzheimer's disease and Aβ toxicity: from top to bottom , 2001, Nature Reviews Neuroscience.

[56]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[57]  C. Aine,et al.  Multistart Algorithms for MEG Empirical Data Analysis Reliably Characterize Locations and Time Courses of Multiple Sources , 2000, NeuroImage.

[58]  A. Nordberg,et al.  Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease , 2000, Neurobiology of Aging.

[59]  A. Belger,et al.  Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating , 1999, Biological Psychiatry.

[60]  M. V. Boland,et al.  Multivariate Analysis , 1998, Current protocols in cytometry.

[61]  R Freedman,et al.  Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. , 1996, Archives of general psychiatry.

[62]  S. Supek,et al.  Simulation studies of multiple dipole neuromagnetic source localization: model order and limits of source resolution , 1993, IEEE Transactions on Biomedical Engineering.

[63]  R. Freedman,et al.  Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics , 1992, Biological Psychiatry.

[64]  A D Baddeley,et al.  The decline of working memory in Alzheimer's disease. A longitudinal study. , 1991, Brain : a journal of neurology.

[65]  P H Crandall,et al.  The magnetic field of epileptic spikes agrees with intracranial localizations in complex partial epilepsy , 1988, Neurology.

[66]  D. Marquardt.  An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[67]  J. H. Ward.  Hierarchical Grouping to Optimize an Objective Function , 1963 .

[68]  N. Smirnov.  Table for Estimating the Goodness of Fit of Empirical Distributions , 1948 .

[69]  H. B. Mann,et al.  On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .

[70]  Kenneth Levenberg.  A METHOD FOR THE SOLUTION OF CERTAIN NON – LINEAR PROBLEMS IN LEAST SQUARES , 1944 .

[71]  Julia M. Stephen,et al.  MEG-SIM Web Portal: A Database of Realistic Simulated and Empirical MEG Data for Testing Algorithms , 2019, Magnetoencephalography.

[72]  J. Haxby,et al.  THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES Alzheimer's Disease: Metabolic Uncoupling of Associative Brain Regions , 2015 .

[73]  Ricardo Bruña,et al.  Influence of the APOE ε4 allele and mild cognitive impairment diagnosis in the disruption of the MEG resting state functional connectivity in sources space. , 2015, Journal of Alzheimer's disease : JAD.

[74]  Doug Ranken,et al.  MRIVIEW: A Software Package for the Analysis and Visualization of Brain Imaging Data , 2014 .

[75]  Fernando Maestú,et al.  Functional connectivity in mild cognitive impairment during a memory task: implications for the disconnection hypothesis. , 2010, Journal of Alzheimer's disease : JAD.

[76]  P. Hof,et al.  Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience , 2006, Acta Neuropathologica.

[77]  D. Small,et al.  Alzheimer's disease and Abeta toxicity: from top to bottom. , 2001, Nature reviews. Neuroscience.

[78]  M Huang,et al.  Multi-start downhill simplex method for spatio-temporal source localization in magnetoencephalography. , 1998, Electroencephalography and clinical neurophysiology.

[79]  C J Aine,et al.  Spatio‐temporal modeling of neuromagnetic data: I. Multi‐source location versus time‐course estimation accuracy , 1997, Human brain mapping.

[80]  M. Bartlett.  Properties of Sufficiency and Statistical Tests , 1992 .

[81]  Richard C. Atkinson,et al.  Human Memory: A Proposed System and its Control Processes , 1968, Psychology of Learning and Motivation.

[82]  P. Venables,et al.  INPUT DYSFUNCTION IN SCHIZOPHRENIA. , 1964, Progress in experimental personality research.